$11.05
+0.05 (+0.45%)
Open$11.09
Previous Close$11.00
Day High$11.44
Day Low$10.93
52W High$17.65
52W Low$2.95
Volume—
Avg Volume911.8K
Market Cap818.19M
P/E Ratio—
EPS$-2.02
SectorPharmaceuticals
Analyst Ratings
Buy
11 analysts
Price Target
+489.8% upside
Current
$11.05
$11.05
Target
$65.17
$65.17
$47.12
$65.17 avg
$100.64
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 179.53M | 176.40M | 195.82M |
| Net Income | 39.25M | 28.13M | 36.61M |
| Profit Margin | 21.9% | 16.0% | 18.7% |
| EBITDA | 43.74M | 50.64M | 56.07M |
| Free Cash Flow | 39.04M | 39.72M | 27.68M |
| Rev Growth | -2.9% | +12.2% | +10.8% |
| Debt/Equity | 0.71 | 0.72 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |